Opinion
Video
The Impact of Biomarkers and Modern Disease-Modifying Therapies in MS
Author(s):
Panelists discuss how modern multiple sclerosis (MS) management has evolved from symptomatic treatment to a proactive, personalized approach leveraging advanced biomarkers and sophisticated disease-modifying therapies. The focus has shifted toward early intervention, precise monitoring, and comprehensive disease control, significantly improving patient outcomes and quality of life.
Video content above is prompted by the following:
- Please share how your management of MS has changed in recent years with the availability of biomarkers and highly efficacious disease-modifying therapies.
Related Videos
Related Content
